TY - JOUR
T1 - New insights into lipid raft function regulating myocardial vascularization competency in human idiopathic dilated cardiomyopathy
AU - Roura, Santiago
AU - Gálvez-Montón, Carolina
AU - Pujal, Josep M.
AU - Casani, Laura
AU - Fernández, Marco A.
AU - Astier, Laura
AU - Gastelurrutia, Paloma
AU - Domingo, Maite
AU - Prat-Vidal, Cristina
AU - Soler-Botija, Carolina
AU - Llucià-Valldeperas, Aida
AU - Llorente-Cortés, Vicenta
AU - Bayes-Genis, Antoni
PY - 2013/10/1
Y1 - 2013/10/1
N2 - Objective: Idiopathic dilated cardiomyopathy (IDCM) affects myocardial vascularization. Whether a lack of demand for increased myocardial vascularization and/or an impaired response of circulating angiogenic-supportive cells are responsible for the vascular derangements found in IDCM is unknown. Methods and results: Left ventricle (LV) samples obtained at transplant from IDCM hearts were compared to control hearts from non-cardiac decedents. Peripheral colony-forming myeloid cells were extracted from age- and sex-matched IDCM patients and healthy volunteers. At the tissue level, no differences were detected in stromal cell-derived factor (SDF)-1α expression, but integrin-linked kinase (ILK) levels and activity were increased in IDCM. A marked co-localization of SDF-1α and the specific marker of cholesterol-enriched lipid rafts Flotillin (Flot)-1 was found in IDCM. SDF-1α was also highly distributed into IDCM lipid rafts. Non-adherent pro-angiogenic cells from both groups, which were found increased in patients but showed similar surface levels of CXCR-4, equally supported Matrigel-mediated cell network formation. However, SDF-1-mediated migration was reduced in IDCM-derived cells, which also exhibited decreased ILK activity and downstream ERK activation. Conclusions: Taken together, our results point out that myocardial competency to increase vascularization is not altered in IDCM, but dysfunctional SDF-1-mediated migration by peripheral pro-angiogenic cells through ILK and downstream ERK signaling may compromise endothelial recovery in patients. We provide new insights into lipid raft function in human IDCM and envision more effective treatments. © 2013 Elsevier Ireland Ltd.
AB - Objective: Idiopathic dilated cardiomyopathy (IDCM) affects myocardial vascularization. Whether a lack of demand for increased myocardial vascularization and/or an impaired response of circulating angiogenic-supportive cells are responsible for the vascular derangements found in IDCM is unknown. Methods and results: Left ventricle (LV) samples obtained at transplant from IDCM hearts were compared to control hearts from non-cardiac decedents. Peripheral colony-forming myeloid cells were extracted from age- and sex-matched IDCM patients and healthy volunteers. At the tissue level, no differences were detected in stromal cell-derived factor (SDF)-1α expression, but integrin-linked kinase (ILK) levels and activity were increased in IDCM. A marked co-localization of SDF-1α and the specific marker of cholesterol-enriched lipid rafts Flotillin (Flot)-1 was found in IDCM. SDF-1α was also highly distributed into IDCM lipid rafts. Non-adherent pro-angiogenic cells from both groups, which were found increased in patients but showed similar surface levels of CXCR-4, equally supported Matrigel-mediated cell network formation. However, SDF-1-mediated migration was reduced in IDCM-derived cells, which also exhibited decreased ILK activity and downstream ERK activation. Conclusions: Taken together, our results point out that myocardial competency to increase vascularization is not altered in IDCM, but dysfunctional SDF-1-mediated migration by peripheral pro-angiogenic cells through ILK and downstream ERK signaling may compromise endothelial recovery in patients. We provide new insights into lipid raft function in human IDCM and envision more effective treatments. © 2013 Elsevier Ireland Ltd.
KW - Angiogenic-supportive myeloid cells
KW - Idiopathic dilated cardiomyopathy
KW - ILK
KW - Lipid rafts
KW - SDF-1
U2 - 10.1016/j.atherosclerosis.2013.08.009
DO - 10.1016/j.atherosclerosis.2013.08.009
M3 - Article
SN - 0021-9150
VL - 230
SP - 354
EP - 364
JO - Atherosclerosis
JF - Atherosclerosis
IS - 2
ER -